03.10.2024 • NewsSK PharmtecoinvestmentSmall Molecules

SK Pharmteco to Expand Production in South Korea

South Korean contract development and manufacturing organization (CDMO) SK Pharmteco announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment to construct a new facility in Sejong, South Korea.

Scheduled to begin operations in late 2026, the new facility will be the fifth plant the company opens in South Korea. According to SK Pharmteco, it will span 135,800 square feet and feature eight production trains with an output of tens of metric tons annually. The investment also includes peptide R&D facilities, CGMP kilo labs, and CGMP pilot plant for peptide manufacturing. With these resources, SK Pharmteco said that it can support early-stage clinical and commercial production with great flexibility. SK Pharmteco plans to hire over 300 new employees at the Sejong site.

Another part of the investment is the construction of the shell for a sixth manufacturing plant, which will allow a quick expansion of capacity in the future.

Joerg Ahlgrimm, CEO of SK Pharmteco, said: “By investing in this new facility, we’re increasing our capacity in Asia in line with our global expansion strategy and solidifying our position as a trusted partner for companies developing groundbreaking treatments, demonstrating our adaptability and reliability in a rapidly changing industry.”

“Our new facility represents a significant investment in our future and a commitment to delivering exceptional value to our customers,” said Yongwoo Park, SK Pharmteco’s president, Small Molecule, Asia. “By expanding our capacity and capabilities, we can offer even faster turnaround times, increased flexibility, and a higher level of quality.”

SK Pharmteco’s current site in Sejong, South Korea. © SK Pharmteco
SK Pharmteco’s current site in Sejong, South Korea. © SK Pharmteco

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.